You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Vaccine supply abroad to continue after domestic requirement: MEA

The Ministry of External Affairs on Thursday said the supply of made-in-India vaccines abroad would continue while also taking care of the country's domestic requirements.

Topics
Coronavirus Vaccine | Ministry of External Affairs

Press Trust of India  |  New Delhi 

vaccine, vaccination, coronavirus, covid, medical, health, drugs

Asserting that India has not imposed any export ban on anti-coronavirus vaccines, the on Thursday said the supply of made-in-India vaccines abroad would continue while also taking care of the country's domestic requirements.

The MEA's assertion comes amid an ongoing debate over export of vaccines with some states having flagged a "shortage" of doses and the Centre maintaining that sufficient quantity of the jabs have been allocated to all the states and that many of them have been unable to inoculate all eligible beneficiaries.

Asked about the status of made-in-India vaccine export and whether domestic calls flagging vaccine shortages could impact the supply abroad, Spokesperson Arindam Bagchi said, "We have always said the supply of made-in-India vaccines abroad would continue taking into account our domestic requirements."

"Let me reiterate that there is no ban on export of vaccines. In fact, the website of our ministry is being regularly updated to reflect the supply of vaccines that are happening on a periodic basis," he said.

On a question on AstraZeneca sending notice to the Serum Institute of India for not fulfilling its international commitment under 'GAVI' and 'COVAX', Bagchi said, "Regarding the issue specific to Serum institute, I would refer you to the company itself, they would be best placed to answer that question."


On the issue of procurement of raw materials from the US for vaccines manufacturing, the MEA spokesperson recalled that Foreign Secretary Harsh Vardhan Shringla had informed during a media briefing that the issue had been taken up with the US.

India is one of the world's biggest drugmakers, and an increasing number of countries have already approached it for procuring anti-coronavirus vaccines.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, April 08 2021. 22:02 IST
RECOMMENDED FOR YOU